Top

Published in:

01-04-2014 | Research Article

Foxp3 promoter polymorphism (rs3761548) in breast cancer progression: a study from India

Authors: Parveen Jahan, V. R. Vinish Ramachander, G. Maruthi, S. Nalini, K. Prasanna Latha, T. S. R. Murthy

Published in: Tumor Biology | Issue 4/2014

Abstract

Breast cancer is the most common female neoplasm that drives the transformation of normal mammary epithelial cells into highly malignant derivatives. Forkhead Box Protein3 (Foxp3), a tumor suppressor/immunomodulatory gene, which controls the function of Treg cells and oncogenes is down regulated in breast cancer. The main aim of the present study is to evaluate the potential influence of Foxp3-3279 C>A polymorphism (rs3761548) and -2383 C>T polymorphism (rs3761549) in 202 breast cancer patients and 130 normal healthy women of Indian origin. The genotypes were determined using ARMS-PCR for rs3761548 and PCR-RFLP method for rs3761549 using specific primers. The results revealed lack of association of these two polymorphisms with breast cancer susceptibility. However, with respect to AA genotype of rs3761548, we found highly significant association with the advanced stage (T3-4) of the tumor (OR = 3.90; 95 % confidence interval (CI) = 1.56–9.70; p = 0.03). Stratified data also revealed an association of homozygous mutant genotype with advanced stage of tumor in premenopausal women (OR = 4.56; 95 % CI = 1.07–19.38; p = 0.04) with disease duration of <6 months (OR = 6.10; 95 % CI = 1.80–20.50; p = 0.002) suggestive of modulating effect of rs3761548 in tumor progression. We conclude that Foxp3 rs37161548 has a potential to be a polymorphic marker for tumor progression in premenopausal breast cancer patients in Indian women.

Forouzanfar MH, Foreman KJ, Delossantos AM, Lozano R, Lopez AD, Murray CJ. Breast and cervical cancer in 187 countries between 1980 and 2010: a systematic analysis. Lancet. 2011;378(9801):1461–84.PubMedCrossRef

American Cancer Society Facts and Figures 2013. http://www.cancer.org/research/cancerfactsfigures/index

Coffer PJ, Burgering BM. Forkhead Box transcription factors and their role in the immune system. Nat Rev Immunol. 2004;4:889–99.PubMedCrossRef

Bennett CL, Christie J, Ramsdell F, et al. The immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome (IPEX) is caused by mutation of FOXP3. Nat Genet. 2001;27(1):20–1.PubMedCrossRef

Fontenot JD, Gavin MA, Rudensky AY. Foxp3 programs the development and function of CD4+ CD25+ regulatory T-cells. Nat Immunol. 2003;4:330–4.PubMedCrossRef

Hori S, Nomura T, Sakaguchi S. Control of regulatory T cell development by the transcription factor Foxp3. Science. 2003;299:1057–61.PubMedCrossRef

Jian Zheng, Jieqiong Deng, Lan Jiang, Lei Yang, Yonghe You, Min Hu, Na Li, Hongchun Wu, Wei Li, Hongbin Li, Jiachun Lu, and Yifeng Zhou. Heterozygous Genetic Variations of FOXP3 in Xp11.23 Elevate Breast Cancer Risk in Chinese Population via Skewed X-Chromosome Inactivation. Human Mutation. 2013; 619-628. doi:10.1002/humu.22284.

Zuo T, Liu R, Zhang H, Chang X, Liu Y, Wang L, et al. FOXP3 is a novel transcriptional repressor for the breast cancer oncogene SKP2. J Clin Invest. 2007a;117:3765–73.

Zuo T, Wang L, Morrison C, Chang X, Zhang H, Li W, et al. FOXP3 is an X-linked breast cancer suppressor gene and an important repressor of the HER-2/ErbB2 oncogene. Cell. 2007;129:1275–86.PubMedCentralPubMedCrossRef

10.

Merlo A, Casalini P, Carcangiu ML, Malventano C, Triulzi T, Menard S, et al. FOXP3 expression and overall survival in breast cancer. J ClinOncol. 2009;27:1746–52.CrossRef

11.

Prieto GA, Rosenstein Y. Oestradiol potentiates the suppressive function of human CD4 CD25 regulatory T cells by promoting their proliferation. Immunology. 2006;118:58–65.PubMedCentralPubMedCrossRef

12.

Oda JMM, Hirata BKB, Guembarovski RL, Watanabe MAE. Genetic polymorphism in FOXP3 gene: imbalance in regulatory T-cell role and development of human diseases. J Genet. 2013;92:163–71.PubMedCrossRef

13.

Tippisetty S, Ishaq M, Komaravalli PL, Jahan P. Angiotensisn converting enzyme (ACE) gene polymorphism in vitiligo: protective and predisposing effects of genotypes in disease susceptibility and progression. Eur J Dermatomal. 2011;21(2):173–7.

14.

Parveen J, Rajeshwari C, Surekha T, Prasanna Latha K, Vijayalakshmi V, Mohammed I. Association of FOXP3 (rs3761548) promoter polymorphism with nondermatomal vitiligo: a study from India. J Am Acad Dermatol. 2013. doi:10.1016/j.jaad.2013.01.035.

15.

Owen CJ, Eden JA, Jennings CE, Wilson V, Cheetham TD, Pearce SH. Genetic association studies of the FOXP3 gene in Graves’ disease and autoimmune Addison’s disease in the United Kingdom population. J Mol Endocrinol. 2006;37:97–104.PubMedCrossRef

16.

Schreiber RD, Old LJ, Smyth MJ. Cancer immunoediting; integrating immunity’s roles in cancer suppression and promotion. Science. 2011;331:1565–70.PubMedCrossRef

17.

Vesely MD, Kershaw MH, Schreiber Schreiber RD, Smyth MJ. Natural innate and adaptive immunity to cancer. Annu Rev Immunol. 2011;29:235–71.PubMedCrossRef

18.

Kobayashi I, Shiari R, Yamada M, Kawamura N, Okano M, Yara A, et al. Novel mutations of FOXP3 in two Japanese patients with immune dysregulation, polyendocrinopathy, enteropathy, X linked syndrome (IPEX). J Med Genet. 2001;38(12):874–6.PubMedCentralPubMedCrossRef

19.

Hinz S, Pagerols-Raluy L, Oberg HH, Ammerpohl O, Grussel S, Sipos B, et al. Foxp3 expression in pancreatic carcinoma cells as a novel mechanism of immune evasion in cancer. Cancer Res. 2007;67:8344–50.PubMedCrossRef

20.

Liu R, Wang L, Chen G, et al. Foxp3 up-regulates p21 expression by site-specific inhibition of histone deacetylase 2/histone deacetylase 4 association to the locus. Cancer Res. 2009;69:2252–9.PubMedCentralPubMedCrossRef

21.

Nesselhut J, Lorenzen DR, Marx D. Cellular immune suppression in cancer patients and its implication for dendritic cell therapy. J ClinOncol. 2009;27:3028.

22.

Raskin L, Rennert G, Gruber SB. FOXP3 germline polymorphisms are not associated with risk of breast cancer. CancerGenet Cytogenet. 2009;190:40–2.CrossRef

23.

Andre GM, Barbosa CP, Teles JS, Vilarino FL, Christofolini DM, Bianco B. Analysis of FOXP3 polymorphisms in infertile women with and without endometriosis. Fertil Steril. 2011;95:2223–7.PubMedCrossRef

24.

Park O, Grishina I, Leung PS, Gershwin ME, Prindiville T. Analysis of the Foxp3/scurfin gene in Crohn’s disease. Ann N Y Acad Sci. 2005;1051:218–28.PubMedCrossRef

25.

Gao L, Li K, Li F, Li H, Liu L, Wang L, et al. Polymorphisms in the FOXP3 gene in Han Chinese psoriasis patients. J Dermatol Sci. 2010;57:51–6.PubMedCrossRef

26.

Zhang L, Zhang Y, Desrosiers M, Wang C, Zhao Y, Han D. Genetic association study of FOXP3 polymorphisms in allergic rhinitis in a Chinese population. Hum Immunol. 2009;70:930–4.PubMedCrossRef

27.

Inoue N, Watanabe M, Morita M, Tomizawa R, Akamizu T, Tatsumi K, et al. Association of functional polymorphisms related to the transcriptional level of FOXP3 with prognosis of autoimmune thyroid diseases. Clin Exp Immunol. 2010;162:402–6.PubMedCentralPubMedCrossRef

28.

Wu Z, You Z, Zhang C, Li Z, Su X, Zhang X, et al. Association between functional polymorphisms of Foxp3 gene and the occurrence of unexplained recurrent spontaneous abortion in a Chinese Han population. Clin Dev Immunol. 2012. doi:10.1155/2012/896458.

29.

Jahan P, Sreenivasagari R, Goudi D, Komaravalli PL, Ishaq M. Role of Foxp3 gene in maternal susceptibility to pre-eclampsia – a study from South India. Scand J Immunol. 2012;77:104–8.CrossRef

30.

Zahra M, Nasrollah E, Mohammad Reza H, Seyed Vahid H, Abbas G. Association of Foxp3/scurfin germline polymorphism (C2383T/rs3761549) with colorectal cancer. Ann Colorectal Res. 2013;1:12–6. doi:10.5812/acr.11478.

31.

Gustavo Andre M, Caio Barbosa P, Juliana Teles S, Fabia Vilarino L, Denise Christofolini M, Bianca B. Analysis of FOXP3 polymorphisms in infertile women with and without endometriosis. J Fertil Steril. 2011. doi:10.1016/j.fertnstert.2011.03.033.

32.

Shen Z, Chen L, Hao F, Wang G, Liu Y. Intron-1 rs3761548 is related to the defective transcription of Foxp3 in psoriasis through abrogating E47/c-Myb binding. J Cell Mol Med. 2010;14:226–41.PubMedCrossRef

33.

Mahmoud SM, Paish EC, Powe DG, Macmillan RD, Lee AH, Ellis IO, et al. An evaluation of the clinical significance of FOXP3+ infiltrating cells in human breast cancer. Breast Cancer Res. 2010. doi:10.1007/s10549-010-0987-8.

34.

Heather Eliassen A, Stacey Missmer A, Shelleys T, Donna S, Robert Barbieri L, Mitch D, et al. Endogenous steroid hormone concentration and risk of breast cancer among premenopausal women. J Natl Cancer Inst. 2006. doi:10.1093/jnci/djj376.PubMed

35.

Polanczyk MJ, Hopke C, Vandenbark AA, Offner H. Estrogen-mediated immunomodulation involves reduced activation of effector T cells, potentiation of Treg cells, and enhanced expression of the PD-1 costimulatory pathway. J Neurosci Res. 2006;84:370–8.PubMedCrossRef

Title: Foxp3 promoter polymorphism (rs3761548) in breast cancer progression: a study from India
Authors: Parveen Jahan
V. R. Vinish Ramachander
G. Maruthi
S. Nalini
K. Prasanna Latha
T. S. R. Murthy
Publication date: 01-04-2014
Publisher: Springer Netherlands
Published in: Tumor Biology / Issue 4/2014
Print ISSN: 1010-4283
Electronic ISSN: 1423-0380
DOI: https://doi.org/10.1007/s13277-013-1501-9

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras

Prof. Fabrice Barlesi

Developed by: Springer Medicine

At a glance: The STEP trials

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 4/2014

Piperine induces apoptosis of lung cancer A549 cells via p53-dependent mitochondrial signaling pathway

FokI polymorphism in vitamin D receptor gene and risk of breast cancer among Caucasian women

Reduced mRNA expression levels of MBD2 and MBD3 in gastric carcinogenesis

Downregulated expression of metastasis associated in colon cancer 1 (MACC1) reduces gallbladder cancer cell proliferation and invasion

Effect of cyclin G2 on proliferative ability of prostate cancer PC-3 cell

The association of APE1 Asp148Glu gene polymorphisms and lung cancer risk: an updated meta-analysis

Keynote webinar | Spotlight on antibody–drug conjugates in cancer